The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Marksans Pharma Ltd. Share Price
Marksans Pharma Ltd. (INR)216.84-0.5 (-0.2%) 
Exchange ScripsBSE524404NSEMARKSANSISININE750C01026
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Marksans Pharma Ltd. Performance
Market performance
Open price219
High221.89
Volumes1777507
Prev Close216.84
Low214.5
Closing date2025-03-21
Historical performance
1 Year High358.70
3 Year High358.70
5 Year High358.70
1 Year Low130.00
3 Year Low38.60
5 Year Low9.85
Marksans Pharma Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
9902
Face Value (₹)
1
P/E Ratio
31.32
Dividend Yield
0.28 %
Marksans Pharma Ltd. Investment Returns
1 Year
49.6%
3 Years
345.7%
5 Years
1745.4%
10 Years
285.8%
Marksans Pharma Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 207 | Bullish |
| 10-DMA | 203.37 | Bullish |
| 20-DMA | 208.35 | Bullish |
| 50-DMA | 233.76 | Bearish |
| 100-DMA | 271.12 | Bearish |
| 200-DMA | 248.74 | Bearish |
Shareholding Pattern
| Field | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
|---|---|---|---|---|---|
| Promoters | 2 | 2 | 2 | 2 | 2 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 2 | 2 | 2 | 2 | 2 |
| Public Investors | 259811 | 248843 | 235498 | 254697 | 237375 |
| Government | --- | --- | --- | --- | --- |
Marksans Pharma Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 504 | 593 | 419 | 67 |
| Operating Profit | 5090 | 3986 | 3007 | 3463 |
| Interest | 112 | 91 | 84 | 80 |
| Depreciation | 743 | 519 | 448 | 362 |
| Profit Before Tax | 4235 | 3377 | 2475 | 3022 |
| Consolidated Net Profit | 3137 | 2663 | 1846 | 2359 |
| Adjusted EPS | 7 | 6 | 5 | 6 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 453 | 453 | 409 | 409 |
| Total Reserves | 20197 | 16998 | 10682 | 8456 |
| Minority Interest | 209 | 199 | 207 | 189 |
| Total Non-Current Liabilities | 2052 | 843 | 571 | 237 |
| Total Liabilities | 26810 | 21904 | 16601 | 12280 |
| Capital Work in Progress | 54 | 72 | 7 | 56 |
| Total Assets | 26810 | 21904 | 16601 | 12280 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 2304 | 2374 | 993 | 1786 |
| Cash Flow from Investing Activities | -1408 | -2592 | -844 | -448 |
| Cash Flow from Financing Activitie | -687 | 1978 | 795 | -153 |
| Net Cash Inflow / Outflow | 208 | 1760 | 944 | 1185 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 31.32.
- 3Y Stock Price CAGR of the stock is 62.1.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹5090 Million.
- The company generated revenue of ₹21774 Million in the previous financial year.
Marksans Pharma Ltd.
216.84-0.5 (-0.2%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1502702.7
No. of Shares: 6930.0
Performance:50.3%
P/L: ₹502702.7
Top Gainers
Top Losers
| Symbol | Change% |
|---|---|
| SALONA | 240.69(-7%) |
| AURIONPRO | 1417.2(-7%) |
| GREENLAM | 274.35(-6%) |
| BALAJEE | 50.94(-6%) |
| PGIL | 1287.5(-5%) |
| RAYMONDLSL | 1082.8(-5%) |
| AGSTRA | 10.7(-5%) |
| KESORAMIND | 6.41(-5%) |
Similar stocks
Announcing Stock of the Month!
